PDB Short entry for 4TVJ HEADER TRANSFERASE 27-JUN-14 4TVJ TITLE HUMAN ARTD2 (PARP2) - CATALYTIC DOMAIN IN COMPLEX WITH OLAPARIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 2, COMPND 5 ARTD2,NAD(+) ADP-RIBOSYLTRANSFERASE 2,ADPRT-2,POLY[ADP-RIBOSE] COMPND 6 SYNTHASE 2,PADPRT-2; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP2, ADPRT2, ADPRTL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS POLY(ADP-RIBOSE) TRANSFERASE, INHIBITOR, ADP-RIBOSYLATION, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,T.EKBLAD,A.F.PINTO,H.SCHULER REVDAT 4 20-DEC-23 4TVJ 1 REMARK REVDAT 3 22-MAR-17 4TVJ 1 JRNL REVDAT 2 18-JAN-17 4TVJ 1 JRNL REVDAT 1 08-JUL-15 4TVJ 0 JRNL AUTH A.G.THORSELL,T.EKBLAD,T.KARLBERG,M.LOW,A.F.PINTO, JRNL AUTH 2 L.TRESAUGUES,M.MOCHE,M.S.COHEN,H.SCHULER JRNL TITL STRUCTURAL BASIS FOR POTENCY AND PROMISCUITY IN JRNL TITL 2 POLY(ADP-RIBOSE) POLYMERASE (PARP) AND TANKYRASE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 1262 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28001384 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00990 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 43558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2293 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3174 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE SET COUNT : 167 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5609 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 267 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.97000 REMARK 3 B22 (A**2) : 0.37000 REMARK 3 B33 (A**2) : -0.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.54000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.220 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.183 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.101 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5815 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3993 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7851 ; 1.530 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9765 ; 1.027 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 705 ; 6.212 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 259 ;36.227 ;24.363 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1042 ;14.919 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;16.891 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 853 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6371 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1125 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3522 ; 0.805 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1429 ; 0.190 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5657 ; 1.471 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2293 ; 2.319 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2188 ; 3.724 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 223 A 579 REMARK 3 ORIGIN FOR THE GROUP (A): 13.9670 -0.0870 16.2690 REMARK 3 T TENSOR REMARK 3 T11: 0.0291 T22: 0.0161 REMARK 3 T33: 0.0412 T12: -0.0058 REMARK 3 T13: 0.0087 T23: -0.0144 REMARK 3 L TENSOR REMARK 3 L11: 0.6516 L22: 0.1652 REMARK 3 L33: 0.5152 L12: -0.0854 REMARK 3 L13: -0.1402 L23: -0.0845 REMARK 3 S TENSOR REMARK 3 S11: -0.0649 S12: 0.0280 S13: -0.0070 REMARK 3 S21: 0.0367 S22: 0.0267 S23: -0.0038 REMARK 3 S31: 0.0012 S32: -0.0050 S33: 0.0381 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 226 B 579 REMARK 3 ORIGIN FOR THE GROUP (A): 29.8520 -32.7100 9.0590 REMARK 3 T TENSOR REMARK 3 T11: 0.0760 T22: 0.0343 REMARK 3 T33: 0.0145 T12: -0.0277 REMARK 3 T13: 0.0160 T23: 0.0036 REMARK 3 L TENSOR REMARK 3 L11: 0.4920 L22: 0.5129 REMARK 3 L33: 0.6167 L12: 0.1372 REMARK 3 L13: -0.2594 L23: 0.3170 REMARK 3 S TENSOR REMARK 3 S11: -0.0358 S12: -0.0192 S13: -0.0569 REMARK 3 S21: -0.1095 S22: 0.0628 S23: -0.0548 REMARK 3 S31: -0.0699 S32: 0.0127 S33: -0.0271 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4TVJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000202357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUL-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99190 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45851 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : 0.10700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.66900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3KCZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.1M TRIS, PH 8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 67.06150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 212 REMARK 465 HIS A 213 REMARK 465 HIS A 214 REMARK 465 HIS A 215 REMARK 465 HIS A 216 REMARK 465 HIS A 217 REMARK 465 HIS A 218 REMARK 465 SER A 219 REMARK 465 SER A 220 REMARK 465 GLY A 221 REMARK 465 VAL A 222 REMARK 465 MET B 212 REMARK 465 HIS B 213 REMARK 465 HIS B 214 REMARK 465 HIS B 215 REMARK 465 HIS B 216 REMARK 465 HIS B 217 REMARK 465 HIS B 218 REMARK 465 SER B 219 REMARK 465 SER B 220 REMARK 465 GLY B 221 REMARK 465 VAL B 222 REMARK 465 ASP B 223 REMARK 465 LEU B 224 REMARK 465 GLY B 225 REMARK 465 GLU B 350 REMARK 465 LEU B 351 REMARK 465 GLN B 352 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 223 CG OD1 OD2 REMARK 470 GLN A 510 CD OE1 NE2 REMARK 470 TYR A 552 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN B 228 CG OD1 ND2 REMARK 470 GLN B 232 CG CD OE1 NE2 REMARK 470 TYR B 552 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 316 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 394 50.70 -107.71 REMARK 500 ARG A 570 -43.95 -138.33 REMARK 500 GLN B 232 78.98 64.53 REMARK 500 HIS B 294 -30.04 -143.36 REMARK 500 ARG B 322 -5.08 -141.25 REMARK 500 HIS B 394 55.36 -109.48 REMARK 500 ASP B 410 117.57 -38.01 REMARK 500 ASP B 550 -84.26 -103.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 09L A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 09L B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KCZ RELATED DB: PDB REMARK 900 3KCZ CONTAINS THE SAME PROTEIN COMPLEXED WITH 3-AMINOBENZAMIDE. REMARK 900 RELATED ID: 3KJD RELATED DB: PDB REMARK 900 3KJD CONTAINS THE SAME PROTEIN COMPLEXED WITH ABT-888 (VELIPARIB). REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE MISMATCH IS DUE TO SEQUENCE CONFLICTS BETWEEN UNIPROT REMARK 999 AND GENBANK (ID AF085734.1). IN THIS CASE AUTHORS HAVE USED THE REMARK 999 SEQUENCE FROM GENBANK (HTTP://WWW.NCBI.NLM.NIH.GOV/NUCCORE/4808556), REMARK 999 HERE RESIDUE 447 IS HISTIDINE. DBREF 4TVJ A 235 579 UNP Q9UGN5 PARP2_HUMAN 235 579 DBREF 4TVJ B 235 579 UNP Q9UGN5 PARP2_HUMAN 235 579 SEQADV 4TVJ MET A 212 UNP Q9UGN5 INITIATING METHIONINE SEQADV 4TVJ HIS A 213 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS A 214 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS A 215 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS A 216 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS A 217 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS A 218 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ SER A 219 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ SER A 220 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLY A 221 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ VAL A 222 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ ASP A 223 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ LEU A 224 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLY A 225 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ THR A 226 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLU A 227 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ ASN A 228 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ LEU A 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ TYR A 230 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ PHE A 231 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLN A 232 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ SER A 233 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ MET A 234 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS A 447 UNP Q9UGN5 PRO 447 CONFLICT SEQADV 4TVJ MET B 212 UNP Q9UGN5 INITIATING METHIONINE SEQADV 4TVJ HIS B 213 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS B 214 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS B 215 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS B 216 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS B 217 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS B 218 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ SER B 219 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ SER B 220 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLY B 221 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ VAL B 222 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ ASP B 223 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ LEU B 224 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLY B 225 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ THR B 226 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLU B 227 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ ASN B 228 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ LEU B 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ TYR B 230 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ PHE B 231 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ GLN B 232 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ SER B 233 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ MET B 234 UNP Q9UGN5 EXPRESSION TAG SEQADV 4TVJ HIS B 447 UNP Q9UGN5 PRO 447 CONFLICT SEQRES 1 A 368 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 368 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASP LEU ARG SEQRES 3 A 368 VAL GLN GLU LEU ILE LYS LEU ILE CYS ASN VAL GLN ALA SEQRES 4 A 368 MET GLU GLU MET MET MET GLU MET LYS TYR ASN THR LYS SEQRES 5 A 368 LYS ALA PRO LEU GLY LYS LEU THR VAL ALA GLN ILE LYS SEQRES 6 A 368 ALA GLY TYR GLN SER LEU LYS LYS ILE GLU ASP CYS ILE SEQRES 7 A 368 ARG ALA GLY GLN HIS GLY ARG ALA LEU MET GLU ALA CYS SEQRES 8 A 368 ASN GLU PHE TYR THR ARG ILE PRO HIS ASP PHE GLY LEU SEQRES 9 A 368 ARG THR PRO PRO LEU ILE ARG THR GLN LYS GLU LEU SER SEQRES 10 A 368 GLU LYS ILE GLN LEU LEU GLU ALA LEU GLY ASP ILE GLU SEQRES 11 A 368 ILE ALA ILE LYS LEU VAL LYS THR GLU LEU GLN SER PRO SEQRES 12 A 368 GLU HIS PRO LEU ASP GLN HIS TYR ARG ASN LEU HIS CYS SEQRES 13 A 368 ALA LEU ARG PRO LEU ASP HIS GLU SER TYR GLU PHE LYS SEQRES 14 A 368 VAL ILE SER GLN TYR LEU GLN SER THR HIS ALA PRO THR SEQRES 15 A 368 HIS SER ASP TYR THR MET THR LEU LEU ASP LEU PHE GLU SEQRES 16 A 368 VAL GLU LYS ASP GLY GLU LYS GLU ALA PHE ARG GLU ASP SEQRES 17 A 368 LEU HIS ASN ARG MET LEU LEU TRP HIS GLY SER ARG MET SEQRES 18 A 368 SER ASN TRP VAL GLY ILE LEU SER HIS GLY LEU ARG ILE SEQRES 19 A 368 ALA HIS PRO GLU ALA PRO ILE THR GLY TYR MET PHE GLY SEQRES 20 A 368 LYS GLY ILE TYR PHE ALA ASP MET SER SER LYS SER ALA SEQRES 21 A 368 ASN TYR CYS PHE ALA SER ARG LEU LYS ASN THR GLY LEU SEQRES 22 A 368 LEU LEU LEU SER GLU VAL ALA LEU GLY GLN CYS ASN GLU SEQRES 23 A 368 LEU LEU GLU ALA ASN PRO LYS ALA GLU GLY LEU LEU GLN SEQRES 24 A 368 GLY LYS HIS SER THR LYS GLY LEU GLY LYS MET ALA PRO SEQRES 25 A 368 SER SER ALA HIS PHE VAL THR LEU ASN GLY SER THR VAL SEQRES 26 A 368 PRO LEU GLY PRO ALA SER ASP THR GLY ILE LEU ASN PRO SEQRES 27 A 368 ASP GLY TYR THR LEU ASN TYR ASN GLU TYR ILE VAL TYR SEQRES 28 A 368 ASN PRO ASN GLN VAL ARG MET ARG TYR LEU LEU LYS VAL SEQRES 29 A 368 GLN PHE ASN PHE SEQRES 1 B 368 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 368 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASP LEU ARG SEQRES 3 B 368 VAL GLN GLU LEU ILE LYS LEU ILE CYS ASN VAL GLN ALA SEQRES 4 B 368 MET GLU GLU MET MET MET GLU MET LYS TYR ASN THR LYS SEQRES 5 B 368 LYS ALA PRO LEU GLY LYS LEU THR VAL ALA GLN ILE LYS SEQRES 6 B 368 ALA GLY TYR GLN SER LEU LYS LYS ILE GLU ASP CYS ILE SEQRES 7 B 368 ARG ALA GLY GLN HIS GLY ARG ALA LEU MET GLU ALA CYS SEQRES 8 B 368 ASN GLU PHE TYR THR ARG ILE PRO HIS ASP PHE GLY LEU SEQRES 9 B 368 ARG THR PRO PRO LEU ILE ARG THR GLN LYS GLU LEU SER SEQRES 10 B 368 GLU LYS ILE GLN LEU LEU GLU ALA LEU GLY ASP ILE GLU SEQRES 11 B 368 ILE ALA ILE LYS LEU VAL LYS THR GLU LEU GLN SER PRO SEQRES 12 B 368 GLU HIS PRO LEU ASP GLN HIS TYR ARG ASN LEU HIS CYS SEQRES 13 B 368 ALA LEU ARG PRO LEU ASP HIS GLU SER TYR GLU PHE LYS SEQRES 14 B 368 VAL ILE SER GLN TYR LEU GLN SER THR HIS ALA PRO THR SEQRES 15 B 368 HIS SER ASP TYR THR MET THR LEU LEU ASP LEU PHE GLU SEQRES 16 B 368 VAL GLU LYS ASP GLY GLU LYS GLU ALA PHE ARG GLU ASP SEQRES 17 B 368 LEU HIS ASN ARG MET LEU LEU TRP HIS GLY SER ARG MET SEQRES 18 B 368 SER ASN TRP VAL GLY ILE LEU SER HIS GLY LEU ARG ILE SEQRES 19 B 368 ALA HIS PRO GLU ALA PRO ILE THR GLY TYR MET PHE GLY SEQRES 20 B 368 LYS GLY ILE TYR PHE ALA ASP MET SER SER LYS SER ALA SEQRES 21 B 368 ASN TYR CYS PHE ALA SER ARG LEU LYS ASN THR GLY LEU SEQRES 22 B 368 LEU LEU LEU SER GLU VAL ALA LEU GLY GLN CYS ASN GLU SEQRES 23 B 368 LEU LEU GLU ALA ASN PRO LYS ALA GLU GLY LEU LEU GLN SEQRES 24 B 368 GLY LYS HIS SER THR LYS GLY LEU GLY LYS MET ALA PRO SEQRES 25 B 368 SER SER ALA HIS PHE VAL THR LEU ASN GLY SER THR VAL SEQRES 26 B 368 PRO LEU GLY PRO ALA SER ASP THR GLY ILE LEU ASN PRO SEQRES 27 B 368 ASP GLY TYR THR LEU ASN TYR ASN GLU TYR ILE VAL TYR SEQRES 28 B 368 ASN PRO ASN GLN VAL ARG MET ARG TYR LEU LEU LYS VAL SEQRES 29 B 368 GLN PHE ASN PHE HET 09L A 601 32 HET GOL A 602 6 HET GOL A 603 6 HET 09L B 601 32 HET GOL B 602 6 HETNAM 09L 4-(3-{[4-(CYCLOPROPYLCARBONYL)PIPERAZIN-1-YL]CARBONYL}- HETNAM 2 09L 4-FLUOROBENZYL)PHTHALAZIN-1(2H)-ONE HETNAM GOL GLYCEROL HETSYN 09L OLAPARIB HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 09L 2(C24 H23 F N4 O3) FORMUL 4 GOL 3(C3 H8 O3) FORMUL 8 HOH *267(H2 O) HELIX 1 AA1 ASP A 223 GLN A 232 1 10 HELIX 2 AA2 ASP A 235 CYS A 246 1 12 HELIX 3 AA3 ASN A 247 MET A 258 1 12 HELIX 4 AA4 PRO A 266 LEU A 270 5 5 HELIX 5 AA5 THR A 271 ALA A 291 1 21 HELIX 6 AA6 GLY A 295 ILE A 309 1 15 HELIX 7 AA7 THR A 323 VAL A 347 1 25 HELIX 8 AA8 HIS A 356 HIS A 366 1 11 HELIX 9 AA9 SER A 376 THR A 389 1 14 HELIX 10 AB1 GLY A 411 PHE A 416 1 6 HELIX 11 AB2 ARG A 431 SER A 433 5 3 HELIX 12 AB3 ASN A 434 GLY A 442 1 9 HELIX 13 AB4 PRO A 451 TYR A 455 5 5 HELIX 14 AB5 MET A 466 ASN A 472 1 7 HELIX 15 AB6 TYR A 473 PHE A 475 5 3 HELIX 16 AB7 LYS A 504 LEU A 509 5 6 HELIX 17 AB8 SER A 525 PHE A 528 5 4 HELIX 18 AB9 ASN A 563 ASN A 565 5 3 HELIX 19 AC1 GLU B 227 GLN B 232 1 6 HELIX 20 AC2 ASP B 235 CYS B 246 1 12 HELIX 21 AC3 ASN B 247 MET B 258 1 12 HELIX 22 AC4 PRO B 266 LEU B 270 5 5 HELIX 23 AC5 THR B 271 GLY B 292 1 22 HELIX 24 AC6 GLY B 295 ILE B 309 1 15 HELIX 25 AC7 THR B 323 VAL B 347 1 25 HELIX 26 AC8 HIS B 356 HIS B 366 1 11 HELIX 27 AC9 SER B 376 THR B 389 1 14 HELIX 28 AD1 GLY B 411 PHE B 416 1 6 HELIX 29 AD2 ARG B 431 SER B 433 5 3 HELIX 30 AD3 ASN B 434 GLY B 442 1 9 HELIX 31 AD4 PRO B 451 TYR B 455 5 5 HELIX 32 AD5 MET B 466 TYR B 473 1 8 HELIX 33 AD6 LYS B 504 LEU B 509 5 6 HELIX 34 AD7 SER B 525 PHE B 528 5 4 HELIX 35 AD8 ASN B 563 ASN B 565 5 3 SHEET 1 AA1 5 CYS A 367 PRO A 371 0 SHEET 2 AA1 5 THR A 398 LYS A 409 -1 O GLU A 406 N ARG A 370 SHEET 3 AA1 5 VAL A 567 ASN A 578 -1 O ASN A 578 N THR A 398 SHEET 4 AA1 5 THR A 482 ALA A 491 -1 N LEU A 487 O TYR A 571 SHEET 5 AA1 5 ARG A 423 GLY A 429 -1 N HIS A 428 O LEU A 486 SHEET 1 AA2 4 ILE A 461 PHE A 463 0 SHEET 2 AA2 4 GLU A 558 VAL A 561 -1 O VAL A 561 N ILE A 461 SHEET 3 AA2 4 SER A 514 GLY A 517 -1 N GLY A 517 O GLU A 558 SHEET 4 AA2 4 CYS A 495 LEU A 498 1 N ASN A 496 O SER A 514 SHEET 1 AA3 3 ALA A 541 ASP A 543 0 SHEET 2 AA3 3 GLY A 519 PRO A 523 -1 N ALA A 522 O SER A 542 SHEET 3 AA3 3 LEU A 554 TYR A 556 1 O ASN A 555 N MET A 521 SHEET 1 AA4 2 VAL A 529 LEU A 531 0 SHEET 2 AA4 2 SER A 534 VAL A 536 -1 O VAL A 536 N VAL A 529 SHEET 1 AA5 5 CYS B 367 PRO B 371 0 SHEET 2 AA5 5 THR B 398 LYS B 409 -1 O GLU B 406 N ARG B 370 SHEET 3 AA5 5 VAL B 567 ASN B 578 -1 O ASN B 578 N THR B 398 SHEET 4 AA5 5 THR B 482 ALA B 491 -1 N GLU B 489 O ARG B 568 SHEET 5 AA5 5 ARG B 423 GLY B 429 -1 N MET B 424 O VAL B 490 SHEET 1 AA6 4 ILE B 461 PHE B 463 0 SHEET 2 AA6 4 GLU B 558 VAL B 561 -1 O VAL B 561 N ILE B 461 SHEET 3 AA6 4 SER B 514 GLY B 517 -1 N THR B 515 O ILE B 560 SHEET 4 AA6 4 CYS B 495 LEU B 498 1 N ASN B 496 O SER B 514 SHEET 1 AA7 3 ALA B 541 ASP B 543 0 SHEET 2 AA7 3 GLY B 519 PRO B 523 -1 N ALA B 522 O SER B 542 SHEET 3 AA7 3 LEU B 554 TYR B 556 1 O ASN B 555 N MET B 521 SHEET 1 AA8 2 VAL B 529 LEU B 531 0 SHEET 2 AA8 2 SER B 534 VAL B 536 -1 O VAL B 536 N VAL B 529 CISPEP 1 GLY A 539 PRO A 540 0 2.48 CISPEP 2 GLY B 539 PRO B 540 0 5.15 SITE 1 AC1 13 GLU A 335 HIS A 428 GLY A 429 ARG A 444 SITE 2 AC1 13 TYR A 455 GLY A 460 ILE A 461 TYR A 462 SITE 3 AC1 13 PHE A 463 SER A 470 TYR A 473 GOL A 603 SITE 4 AC1 13 HOH A 723 SITE 1 AC2 6 ASP A 396 TYR A 397 ALA A 471 ASN A 472 SITE 2 AC2 6 PHE A 475 ALA A 476 SITE 1 AC3 7 SER A 328 ILE A 331 GLU A 335 GLY A 454 SITE 2 AC3 7 TYR A 455 09L A 601 HOH A 854 SITE 1 AC4 11 GLU B 335 HIS B 428 GLY B 429 ARG B 444 SITE 2 AC4 11 TYR B 455 GLY B 460 ILE B 461 TYR B 462 SITE 3 AC4 11 SER B 470 TYR B 473 HOH B 719 SITE 1 AC5 7 ASP B 396 TYR B 397 ALA B 471 ASN B 472 SITE 2 AC5 7 CYS B 474 PHE B 475 ALA B 476 CRYST1 58.083 134.123 58.348 90.00 117.96 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017217 0.000000 0.009140 0.00000 SCALE2 0.000000 0.007456 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019404 0.00000